Medical Press Release - Page 12 of 12 - Medika Life : Keeping you informed

A New Program, Established by The Claims Conference and Funded by The German Government, Will Ensure Holocaust Survivors Globally Have the Means to Get To COVID-19 Vaccine Sites

COVID-19 Testing with 72 Hour or Less Turnaround Time

Medika Life - August 6, 2020

TCA/GENETWORx is building capability to perform 870,000 tests per day or 26 million per month. In order to meet demand, the company launched a massive recruiting campaign called Re Employ America

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life - August 6, 2020

FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Medika Life - September 23, 2020

The first antiviral nasal spray in the United States. Nomovid™ Nasal Spray will be easy-to-use, low-cost and can be quickly made available over-the-counter for consumers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

FINN Partners Brings Aboard the Pharmacy Podcast Network

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

COVID-19 Testing with 72 Hour or Less Turnaround Time

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories